Martin Spillmann
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Martin Spillmann has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Benoit Meger
Paul Scherrer Institute, Laboratory of Nanoscale Biology, PSI, Forschungsstrasse 111, 5232 Villigen, Switzerland
1 shared publication - Gebhard F. X. Schertler
Center for Life Sciences, Paul Scherrer Institute, Villigen, Switzerland
1 shared publication - Larissa Thurner
Paul Scherrer Institute, Laboratory of Nanoscale Biology, PSI, Forschungsstrasse 111, 5232 Villigen, Switzerland
1 shared publication - Maria Waldhoer
InterAx Biotech AG, PARK innovAARE, 5234 Villigen, Switzerland
1 shared publication - Martin Behe
Center for Radiopharmaceutical Science ETH-PSI-USZ Paul Scherrer Institute 5232 Villigen-PSI Switzerland
1 shared publication - Mirjam Zimmermann
InterAx Biotech AG, PARK innovAARE, 5234 Villigen, Switzerland
1 shared publication
Latest Publications
- Open Access
- 13 July 2020
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 21 (14) , 4949
New Insights into Arrestin Recruitment to GPCRs
G protein-coupled receptors (GPCRs) are cellular master regulators that translate extracellular stimuli such as light, small molecules or peptides into a cellular response. Upon ligand binding, they bind intracellular proteins such as G proteins or arrestins, modulating intracellular signaling cascades. Here, we use a protein-fragment complementation approach based on nanoluciferase (split luciferase assay) to assess interaction of all four known human arrestins with four different GPCRs (two class A and two class B receptors) in live cells. Besides directly tagging the 11S split-luciferase subunit to the receptor, we also could demonstrate that membrane localization of the 11S subunit with a CAAX-tag allowed us to probe arrestin recruitment by endogenously expressed GPCRs. Varying the expression levels of our reporter constructs changed the dynamic behavior of our assay, which we addressed with an advanced baculovirus-based multigene expression system. Our detection assay allowed us to probe the relevance of each of the two arrestin binding sites in the different GPCRs for arrestin binding. We observed remarkable differences between the roles of each arresting binding site in the tested GPCRs and propose that the distinct advantages of our system for probing receptor interaction with effector proteins will help elucidate the molecular basis of GPCR signaling efficacy and specificity in different cell types.
- 13 July 2020
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 21 (14) , 4949
Open AccessNew Insights into Arrestin Recruitment to GPCRs
G protein-coupled receptors (GPCRs) are cellular master regulators that translate extracellular stimuli such as light, small molecules or peptides into a cellular response. Upon ligand binding, they bind intracellular proteins such as G proteins or arrestins, modulating intracellular signaling cascades. Here, we use a protein-fragment complementation approach based on nanoluciferase (split luciferase assay) to assess interaction of all four known human arrestins with four different GPCRs (two class A and two class B receptors) in live cells. Besides directly tagging the 11S split-luciferase subunit to the receptor, we also could demonstrate that membrane localization of the 11S subunit with a CAAX-tag allowed us to probe arrestin recruitment by endogenously expressed GPCRs. Varying the expression levels of our reporter constructs changed the dynamic behavior of our assay, which we addressed with an advanced baculovirus-based multigene expression system. Our detection assay allowed us to probe the relevance of each of the two arrestin binding sites in the different GPCRs for arrestin binding. We observed remarkable differences between the roles of each arresting binding site in the tested GPCRs and propose that the distinct advantages of our system for probing receptor interaction with effector proteins will help elucidate the molecular basis of GPCR signaling efficacy and specificity in different cell types.